Following an abbreviated submission.
Olmesartan/hydrochlorothiazide (Olmetec Plus) tablet is accepted for restricted use in NHS Scotland for the treatment of hypertension as an alternative in patients unable to tolerate an ACE inhibitor, whose blood pressure is not adequately controlled by olmesartan 20mg monotherapy and for whom the addition of a thiazide diuretic is an appropriate next step.
There is no additional cost compared to administration of olmesartan alone. The combination is competitively priced compared with other combinations of angiotensin II antagonists and thiazide diuretics. Angiotensin II receptor antagonists are an alternative to angiotensin converting enzyme (ACE) inhibitors where the latter are not tolerated. This fixed dose combination is one of a number of options for the treatment of hypertension, many of which are less expensive.
Download detailed advice29KB (PDF)
- Medicine name:
- Olmesartan/hydrochlorothiazide tablets (Olmetec Plus®)
- SMC ID:
- Pharmaceutical company
- Sankyo Pharma UK Ltd
- BNF chapter
- Cardiovascular system
- Submission type
- Date advice published
- 08 May 2006